Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

ACRES Opens First Clinical Research Affiliate Organization in Japan
  • USA - English


News provided by

Alliance for Clinical Research Excellence and Safety (ACRES)

Oct 07, 2014, 03:50 ET

Share this article

Share toX

Share this article

Share toX

Alliance for Clinical Research Excellence and Safety -- Japan
Alliance for Clinical Research Excellence and Safety -- Japan

ACRES President and CEO Greg Koski said, “This is a remarkable accomplishment by any measure. Organizations from across the Japanese clinical research endeavor have shown extraordinary leadership”

Post this

Cambridge, MA (PRWEB) October 07, 2014 -- The Alliance for Clinical Research Excellence and Safety (ACRES), a Massachusetts-based non-profit operating in the public interest, has taken the first step in its plan to create a globe-spanning framework of regional and national affiliates with the opening of its first national affiliate, ACRES Japan, in Tokyo last week. Dr. Fumimaro Takaku, president of the Japanese Association of Medical Sciences, will provide leadership to ACRES Japan in his role as president of Board of Directors. ACRES Japan will provide a model for ACRES National Affiliates around the world.

Addressing the pervasive dysfunction and inefficiency in today’s fragmented clinical research enterprise—escalating costs, delays, waste, poor site-performance, ethical and legal lapses, public mistrust, decade-long lag-time from discovery to market—ACRES allies are working together to construct a comprehensive, integrated global clinical research system, including a network of high-performing professional sites using common standards, procedures and inter-operable information technologies acceptable world-wide, with a focus on safety, ethics, quality and efficiency.

To meet the needs of the modern clinical research enterprise, any such system must be global. Clinical trials are increasingly conducted internationally, but without standardization or interoperability among the many different stakeholders in the research enterprise.

Further, these diverse stakeholders – including sponsors and CROs, government ministries and regulators, service providers, professional organizations, ethics committees, patients, and research sites – must construct the global system for the benefit of all stakeholders. And demographic challenges, vastly different medical care systems as well as cultural values regarding safety, quality, and transparency must be accommodated.

Accordingly, ACRES utilizes both a stakeholder alliance and a global outreach approach. The organizational structure of ACRES reflects this essential outreach, working through regional coordinating centers and national affiliates to provide both a “home” for the necessary alliances, initiatives and collaborations as well as the focused, visionary leadership to make it happen.

ACRES Japan, ACRES first National Affiliate, was established by organizations within Japan to develop high-quality clinical research both within Japan and worldwide by promoting education and training of investigators and study team members, supporting site accreditation, and developing an IT platform for effective information sharing.

Dr. Fumimaro Takaku, president of ACRES Japan, set high goals for the new organization, noting that "Clinical research must be conducted with high transparency; education and training of physician investigators for clinical research must be rigorous; a code of conduct for physicians collaborating with pharmaceutical companies for clinical search must be assured--addressing these concerns will lead to highest quality and efficiency of clinical research in Japan. Through ACRES Japan, we are committed to finding effective solutions to these challenges.”

In addition to its distinguished Board of Directors, ACRES Japan Executive Officers are Kyoko Imamura, Ichiro Uchida, Kishio Ono, and Yasushi Suzuki. Planned activities range from advocating collaboration among like-minded organizations and individuals across Japan to participating in working groups of ACRES global initiatives and developing clinical research infrastructure in Japan. ACRES Japan will promote activities involved in education and training of investigators and study teams, site accreditation, and the development of an IT platform for global networks linked to hospital information systems.

ACRES Japan will also create mechanisms to facilitate communication and collaboration between ACRES and local academic institutions, regulatory agencies, health systems, professional associations and patient organizations and to identify opportunities to further leverage ACRES-related Initiatives in Japan.

ACRES President Greg Koski applauded his Japanese colleagues, saying, “This is a remarkable accomplishment by any measure. Organizations across the Japanese clinical research endeavor have shown extraordinary leadership, uniting to build a collaborative framework and expectation for excellence, one that will set very high standards and clear pathways for other nations seeking to achieve these goals. We look forward to our work together, not only with Japan, but with other countries worldwide.”

About ACRES

ACRES is a neutral, non-industry organization operating in the public interest. ACRES serves as a home and coordinator for multi-stakeholder collaboration, an incubator for innovation, an adapter of successful models and practices from other highly regulated and complex research-focused industries, an integrator for complex cross-cutting initiatives, a leader offering new ideas and directions and an implementer putting system solutions to work. For more information, please contact Dr. Mary Tobin at mtobin(AT)acresglobal.net.

Dr. Mary F. Tobin, Alliance for Clinical Research Excellence and Safety (ACRES), http://www.acresglobal.net, +1 410-987-5509, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.